Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial Pavel, M., Gross, D., Benavent, M., Caplin, M., Perros, P., Srirajaskanthan, R., Valle, J., Warner, R., Kulke, M., Anthony, L., Kunz, P., Hoersch, D., Oberg, K., Lapuerta, P., Jackson, S., Banks, P., Biran, T., Garcia-Carbonero, R. LIPPINCOTT WILLIAMS & WILKINS. 2017: 434–35

View details for Web of Science ID 000394448600055